Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis

OBJECTIVE: Yupingfeng Powder (YPF), a kind of preventative patent medicine, is chosen for treatment of coronavirus disease 2019 (COVID-19) due to its high frequency application in respiratory tract diseases, such as chronic obstructive pulmonary disease, asthma, respiratory tract infections, and pne...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Linyan, Du, Zhongyan, Guan, Yang, Wang, Bo, Pei, Yanling, Zhang, Lizong, Fang, Mingsun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828289/
https://www.ncbi.nlm.nih.gov/pubmed/35165529
http://dx.doi.org/10.1016/j.chmed.2022.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828289/
https://www.ncbi.nlm.nih.gov/pubmed/35165529
http://dx.doi.org/10.1016/j.chmed.2022.02.001

Ejemplares similares